Back
Dianthus Therapeutics Stock Predictions
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37
DNTH
Dianthus Therapeutics
Last Price:
25.36
Seasonality Move:
19.62%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth: Invest in the Smartphone Revolution @ $0.26/Share
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Dianthus Therapeutics Stock Forecast
- Over the next 52 weeks, Dianthus Therapeutics has on average historically fallen by 5.6% based on the past 6 years of stock performance.
- Dianthus Therapeutics has fallen lower in 4 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Dianthus Therapeutics Stock Undervalued?
The current Dianthus Therapeutics [DNTH] share price is $25.70. The Score for DNTH is 37, which is 26% below its historic median score of 50, and infers higher risk than normal. - DNTH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Dianthus Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Dianthus Therapeutics has on average historically fallen by 5.6% based on the past 6 years of stock performance.
Dianthus Therapeutics Stock Rating
Sell
37
Dianthus Therapeutics (DNTH)
is a Sell
Is Dianthus Therapeutics overpriced?
- Dianthus Therapeutics has fallen lower in 4 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Dianthus Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
dianthustx.com
52-Week Data
52-Week High:
33.77
52-Week Low:
6.58
Prediction Charts
Market Cap:
760.64M
Price in USD:
25.70
Volume:
309.38K
Beta:
2.03
Technical Analysis
SMA50:
26.70
SMA100:
27.34
SMA200:
26.19
52-Wk Change:
128.04%
Stock Predictions
-
Is Dianthus Therapeutics stock public?
Yes, Dianthus Therapeutics is a publicly traded company. -
What is the Dianthus Therapeutics stock quote today?
The Dianthus Therapeutics stock price is 25.70 USD today. -
How to buy Dianthus Therapeutics stock online?
You can buy Dianthus Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-12 | 27.41 | 27.68 | 28.01 | 26.07 |
| Nov-13 | 28.14 | 26.35 | 28.56 | 25.69 |
| Nov-14 | 26.49 | 25.49 | 27.56 | 25.35 |
| Nov-15 | 25.55 | 23.36 | 25.93 | 22.19 |
| Nov-18 | 23.11 | 23.60 | 24.10 | 22.88 |
| Nov-19 | 23.09 | 22.27 | 23.62 | 21.92 |
| Nov-20 | 22.09 | 20.77 | 22.45 | 20.53 |
| Nov-21 | 20.88 | 20.27 | 20.98 | 19.85 |
| Nov-22 | 20.37 | 22.34 | 22.39 | 20.37 |
| Nov-25 | 22.85 | 23.45 | 24.30 | 22.85 |
| Nov-26 | 23.24 | 23.86 | 24.24 | 22.89 |
| Nov-27 | 23.81 | 23.83 | 23.99 | 23.07 |
| Nov-29 | 23.80 | 23.99 | 24.28 | 22.88 |
| Dec-2 | 24.02 | 25.70 | 25.89 | 23.62 |
Dianthus Therapeutics Earnings
Dianthus Therapeutics Earnings Report: Per Share Dianthus Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Dianthus Therapeutics Forecast Revenue Growth
Dianthus Therapeutics Stock Analysis: Historical quarterly revenues per share for Dianthus Therapeutics and historical quarterly revenue growth:
* Dianthus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.